Last reviewed · How we verify

NCT04231123

Pericapsular Nerve Group Block for Elective Hip Arthroplasty

Status unknown NA Last updated 27 January 2021
What this trial tests

NA trial testing PENG Block with local anesthetic in Postoperative Pain in 60 participants. Status unknown.

Timeline
20 January 2020
Primary endpoint
31 December 2021
15 March 2022

Quick facts

Lead sponsorCentre Hospitalier Universitaire de Tivoli
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment60
Start date20 January 2020
Primary completion31 December 2021
Estimated completion15 March 2022
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire de Tivoli

Who can join

Adults 18 to 80, any sex, with Postoperative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study examine the effect of Pericapsular Nerve Group (PENG) Block on analgesia after elective hip arthroplasty. Half of participants will receive a PENG Block with local anesthetic, while the other half will receive a PENG Block with a placebo.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Postoperative Pain

Currently open trials in the same condition.

Other Centre Hospitalier Universitaire de Tivoli trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04231123.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing